Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis

Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/s12962-019-0193-4
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer

Einstein (São Paulo, Brazil)
Medicine
2019English

Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE

Cancer
Cancer ResearchOncology
2018English

Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

JAMA Oncology
Cancer ResearchOncology
2017English

Comparative Clinical Effects and Cost–effectiveness of Maximum Androgen Blockade, Docetaxel With Androgen Deprivation Therapy and ADT Alone for the Treatment of mHSPC in China

Journal of Comparative Effectiveness Research
Health Policy
2019English

Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Mp22-09 Association Between Androgen-Deprivation Therapy and Non-Prostate Cancer Mortality Among Men With Non-Metastatic Prostate Cancer

Journal of Urology
Urology
2018English

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy